AXGN
AxoGen, Inc. NASDAQ Listed Dec 17, 1986$43.43
Mkt Cap $2.3B
52w Low $9.22
93.4% of range
52w High $45.83
50d MA $34.36
200d MA $26.30
P/E (TTM)
-127.3x
EV/EBITDA
7765.2x
P/B
15.5x
Debt/Equity
0.1x
ROE
-12.8%
P/FCF
-513.9x
RSI (14)
—
ATR (14)
—
Beta
0.98
50d MA
$34.36
200d MA
$26.30
Avg Volume
1.1M
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
13631 Progress Boulevard · Alachua, FL 32615 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | TNS | 0.12 | 0.07 | -41.7% | 41.99 | -1.1% | -0.5% | +3.4% | +0.2% | -1.5% | +2.6% | — |
| Feb 24, 2026 | TNS | 0.09 | 0.07 | -21.2% | 32.50 | -1.7% | -3.9% | +2.2% | -0.5% | -3.4% | -2.7% | — |
| Oct 29, 2025 | TNS | 0.09 | 0.12 | +33.3% | 22.25 | +3.0% | +1.9% | -2.0% | +4.6% | +2.2% | -1.6% | — |
| Aug 5, 2025 | TNS | 0.06 | 0.12 | +100.0% | 13.72 | +2.0% | +0.2% | +2.3% | -1.2% | +0.8% | +1.1% | — |
| May 8, 2025 | TNS | -0.01 | -0.02 | -100.0% | 12.59 | +2.2% | -9.7% | +0.2% | -4.5% | +8.6% | -0.3% | — |
| Feb 25, 2025 | TNS | 0.04 | 0.08 | +100.0% | 20.11 | +2.8% | -3.2% | -0.2% | +3.0% | -3.6% | -3.5% | — |
| Nov 7, 2024 | TNS | 0.01 | 0.07 | +1066.7% | 13.27 | +0.4% | -4.6% | +10.3% | -5.0% | -5.5% | -0.6% | — |
| Aug 8, 2024 | TNS | -0.05 | 0.05 | +200.0% | 10.70 | +4.2% | +3.0% | -1.4% | +3.6% | -4.5% | +2.5% | — |
| May 2, 2024 | TNS | -0.10 | -0.06 | +40.0% | 5.88 | +0.2% | -1.5% | -2.1% | +2.8% | +0.7% | +1.9% | — |
| Mar 5, 2024 | TNS | -0.09 | -0.06 | +33.3% | 8.99 | -0.9% | +0.8% | -0.4% | -3.0% | -3.5% | -2.5% | — |
| Nov 7, 2023 | TNS | -0.08 | 0.01 | +112.5% | 5.38 | -0.9% | +0.4% | -6.5% | -0.6% | +2.6% | +9.1% | — |
| Aug 7, 2023 | TNS | -0.15 | -0.03 | +80.0% | 8.28 | -2.5% | -19.4% | +0.2% | -6.5% | -2.9% | +0.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | Wells Fargo | Maintains | Overweight → Overweight | — | $41.99 | $41.52 | -1.1% | -0.5% | +3.4% | +0.2% | -1.5% | +2.6% |
| Apr 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $41.99 | $41.52 | -1.1% | -0.5% | +3.4% | +0.2% | -1.5% | +2.6% |
| Apr 29 | Citizens | Maintains | Market Outperform → Market Outperform | — | $41.99 | $41.52 | -1.1% | -0.5% | +3.4% | +0.2% | -1.5% | +2.6% |
| Apr 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $41.99 | $41.52 | -1.1% | -0.5% | +3.4% | +0.2% | -1.5% | +2.6% |
| Apr 23 | Lake Street | Maintains | Buy → Buy | — | $37.00 | $37.32 | +0.9% | +1.1% | +4.9% | +0.4% | +6.6% | -0.5% |
| Mar 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $31.28 | $31.26 | -0.1% | +0.1% | +5.8% | +1.4% | +2.6% | -5.2% |
| Feb 24 | Citizens | Maintains | Market Outperform → Market Outperform | — | $35.38 | $29.62 | -16.3% | -8.1% | -3.9% | +2.2% | -0.5% | -3.4% |
| Dec 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $32.85 | $32.95 | +0.3% | +1.4% | -7.6% | -0.6% | -2.0% | -0.1% |
| Dec 5 | Canaccord Genuity | Maintains | Buy → Buy | — | $32.85 | $32.95 | +0.3% | +1.4% | -7.6% | -0.6% | -2.0% | -0.1% |
| Dec 4 | Jefferies | Maintains | Buy → Buy | — | $28.33 | $31.07 | +9.7% | +16.0% | +1.4% | -7.6% | -0.6% | -2.0% |
| Dec 4 | Lake Street | Maintains | Buy → Buy | — | $28.33 | $31.07 | +9.7% | +16.0% | +1.4% | -7.6% | -0.6% | -2.0% |
| Oct 30 | Raymond James | Maintains | Outperform → Outperform | — | $22.25 | $22.91 | +3.0% | +1.9% | -2.0% | +4.6% | +2.2% | -1.6% |
| Oct 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $22.25 | $22.91 | +3.0% | +1.9% | -2.0% | +4.6% | +2.2% | -1.6% |
| Oct 30 | Citizens | Maintains | Market Outperform → Market Outperform | — | $22.25 | $22.91 | +3.0% | +1.9% | -2.0% | +4.6% | +2.2% | -1.6% |
| Oct 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $22.25 | $22.91 | +3.0% | +1.9% | -2.0% | +4.6% | +2.2% | -1.6% |
| May 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $11.39 | $11.35 | -0.4% | -4.5% | +8.6% | -0.3% | +0.4% | -0.6% |
| Mar 5 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $18.62 | $18.60 | -0.1% | -2.2% | -2.4% | -0.2% | -3.2% | +1.5% |
| Mar 5 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $18.62 | $18.60 | -0.1% | -2.2% | -2.4% | -0.2% | -3.2% | +1.5% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $20.11 | $20.68 | +2.8% | -3.2% | -0.2% | +3.0% | -3.6% | -3.5% |
| Feb 26 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $20.11 | $20.68 | +2.8% | -3.2% | -0.2% | +3.0% | -3.6% | -3.5% |
| Feb 3 | Canaccord Genuity | Maintains | Buy → Buy | — | $18.21 | $18.16 | -0.3% | -1.6% | +0.9% | +4.4% | -2.9% | -2.0% |
| Aug 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $10.70 | $11.15 | +4.2% | +3.0% | -1.4% | +3.6% | -4.5% | +2.5% |
| Jun 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $7.15 | $7.06 | -1.3% | -4.8% | +2.8% | +3.3% | +0.7% | +3.0% |
| Jan 19 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $8.14 | $8.22 | +1.0% | +7.9% | +3.0% | -2.0% | +3.8% | +3.4% |
| Dec 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $7.30 | $7.32 | +0.3% | +1.6% | +1.2% | +0.5% | -0.7% | +3.5% |
| Sep 26 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $4.99 | $4.88 | -2.2% | -6.2% | +6.8% | +1.2% | -1.2% | +0.0% |
| Aug 22 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $5.98 | $6.02 | +0.7% | +6.9% | +2.0% | -3.1% | +0.3% | +0.8% |
| May 10 | JMP Securities | Maintains | Market Outperform → Outperform | — | $9.32 | $9.44 | +1.3% | +1.8% | -3.4% | +0.5% | +0.1% | -0.2% |
| Mar 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $9.22 | $9.16 | -0.7% | -2.5% | +1.3% | +1.3% | +2.4% | -0.5% |
| Mar 15 | JMP Securities | Maintains | Market Outperform → Outperform | — | $8.43 | $8.23 | -2.4% | -0.4% | -1.5% | -0.6% | +3.2% | +5.1% |
| May 9 | Canaccord Genuity | Upgrade | Hold → Buy | — | $9.03 | $8.81 | -2.4% | +3.2% | -0.1% | -9.5% | +5.1% | +6.1% |
| May 5 | SVB Leerink | Maintains | Outperform → Outperform | — | $8.26 | $9.05 | +9.6% | +18.3% | -7.6% | +3.2% | -0.1% | -9.5% |
| Nov 4 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $15.60 | $14.46 | -7.3% | -15.3% | +3.9% | +4.2% | -6.4% | -3.5% |
| May 6 | Canaccord Genuity | Maintains | Hold → Hold | — | $19.64 | $19.52 | -0.6% | +12.5% | +6.4% | -7.3% | -1.8% | -2.6% |
| Feb 23 | SVB Leerink | Maintains | Outperform → Outperform | — | $21.19 | $22.00 | +3.8% | +1.0% | +3.6% | -2.8% | +2.6% | +2.3% |
| Feb 23 | Canaccord Genuity | Maintains | Hold → Hold | — | $21.19 | $22.00 | +3.8% | +1.0% | +3.6% | -2.8% | +2.6% | +2.3% |
| Oct 23 | Guggenheim | Maintains | Buy → Buy | — | $13.35 | $13.99 | +4.8% | +1.4% | -5.5% | -2.0% | -2.8% | +4.4% |
| Aug 6 | SVB Leerink | Maintains | Outperform → Outperform | — | $12.31 | $13.00 | +5.6% | -2.2% | +1.5% | -4.0% | -3.5% | -0.4% |
| May 7 | Canaccord Genuity | Downgrade | Buy → Hold | — | $9.89 | $9.36 | -5.4% | -15.9% | +7.6% | -1.6% | -1.1% | -4.9% |
| Apr 2 | BTIG | Downgrade | Buy → Neutral | — | $8.68 | $8.23 | -5.2% | -4.7% | -7.1% | +7.2% | -3.0% | +3.1% |
| Nov 7 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $13.28 | $13.50 | +1.7% | +14.0% | +0.7% | +0.1% | +1.0% | -0.6% |
| Nov 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $13.28 | $13.50 | +1.7% | +14.0% | +0.7% | +0.1% | +1.0% | -0.6% |
| Aug 7 | William Blair | Downgrade | Outperform → Market Perform | — | $17.58 | $14.27 | -18.8% | -29.2% | +5.5% | +2.0% | +9.2% | +4.6% |
| Mar 25 | BTIG | Upgrade | Neutral → Buy | — | $20.41 | $21.30 | +4.4% | +4.9% | +0.5% | -4.7% | -0.1% | +2.9% |
| Mar 25 | BTIG Research | Upgrade | Neutral → Buy | — | $20.41 | $21.30 | +4.4% | +4.9% | +0.5% | -4.7% | -0.1% | +2.9% |
| Nov 14 | BTIG Research | Maintains | Neutral → Neutral | — | $33.28 | $33.12 | -0.5% | -3.3% | +2.5% | -3.1% | -11.2% | +3.3% |
| Oct 30 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $32.13 | $33.79 | +5.2% | +11.3% | +4.3% | +2.6% | -3.5% | -2.8% |
| May 1 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $39.80 | $38.50 | -3.3% | -3.6% | +2.2% | +5.9% | +2.4% | +1.5% |
| May 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $39.80 | $38.50 | -3.3% | -3.6% | +2.2% | +5.9% | +2.4% | +1.5% |
| Mar 1 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $29.20 | $31.00 | +6.2% | +16.3% | -2.9% | -1.1% | +1.1% | +4.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Quackenbush DorisOff | Sales VP | Sell | 3,878 | $43.51 | $169K | 92,416 | — | — |
| May 7, 2026 | Weiler Kathy JohnsonDir | — | Sell | 16,344 | $44.09 | $721K | — | — | — |
| May 7, 2026 | Hartley Lindsey MarieOff | CFO | Sell | 573 | $43.67 | $25K | 65,146 | — | — |
| May 7, 2026 | Hartley Lindsey MarieOff | CFO | Sell | 478 | $43.67 | $21K | 62,756 | — | — |
| May 7, 2026 | Kemp JensOff | Chief Marketing Officer | Sell | 4,000 | $43.44 | $174K | 72,451 | — | — |
| May 7, 2026 | JOHNSON JOHNDir | — | Sell | 11,050 | $43.26 | $478K | — | — | — |
8-K · 7.01
! Medium
Axogen, Inc. -- 8-K 7.01: Regulation FD Disclosure
Axogen disclosed a financial results presentation available for investor and analyst discussions, though the filing provides limited detail on specific business updates or financial performance metrics.
Apr 28
8-K · 7.01
! Medium
Axogen, Inc. -- 8-K 7.01: Regulation FD Disclosure
Axogen furnished a financial results presentation for potential use with analysts and investors, signaling routine investor communication and transparency regarding company performance.
Feb 24
Data updated apr 24, 2026 8:11pm
· Source: massive.com